Last reviewed · How we verify

Concentrated Bone Marrow Aspirate Injection

Hospital for Special Surgery, New York · FDA-approved active Biologic

Concentrated bone marrow aspirate delivers autologous stem cells and growth factors to promote tissue regeneration and reduce inflammation at the injection site.

Concentrated bone marrow aspirate delivers autologous stem cells and growth factors to promote tissue regeneration and reduce inflammation at the injection site. Used for Osteoarthritis (knee, hip, shoulder), Cartilage defects, Tendon and ligament injuries.

At a glance

Generic nameConcentrated Bone Marrow Aspirate Injection
Also known ascBMA, BMAC, Bone Marrow Aspirate Concentrate
SponsorHospital for Special Surgery, New York
Drug classAutologous stem cell therapy
ModalityBiologic
Therapeutic areaOrthopedics / Regenerative Medicine
PhaseFDA-approved

Mechanism of action

This product is an autologous cell therapy that concentrates mononuclear cells, mesenchymal stem cells, and hematopoietic stem cells from a patient's own bone marrow. When injected into damaged tissue, these cells and their secreted factors (cytokines, growth factors) promote angiogenesis, reduce inflammation, and stimulate endogenous repair mechanisms. The mechanism leverages the regenerative and immunomodulatory properties of bone marrow-derived stem cells.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: